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Abstract
Garlic and its preparations have been widely recognized as agents for prevention and treatment of
cardiovascular and other metabolic diseases, atherosclerosis, hyperlipidemia, thrombosis,
hypertension and diabetes. Effectiveness of garlic in cardiovascular diseases was more encouraging
in experimental studies, which prompted several clinical trials. Though many clinical trials showed
a positive effect of garlic on almost all cardiovascular conditions mentioned above, however a
number of negative studies have recently cast doubt on the efficary of garlic specially its cholesterol
lowering effect of garlic. It is a great challenge for scientists all over the world to make a proper
use of garlic and enjoy its maximum beneficial effect as it is the cheapest way to prevent
cardiovascular disease. This review has attempted to make a bridge the gap between experimental
and clinical study and to discuss the possible mechanisms of such therapeutic actions of garlic.
Introduction
Dietary factors play a key role in the development of vari-
ous human diseases, including cardiovascular disease. Ep-
idemiological studies have shown that diets rich in fruits,
herbs and spices are associated with a low risk of cardio-
vascular disease. Garlic acquired a reputation in the folk-
lore of many cultures over centuries as a formidable
prophylactic and therapeutic medicinal agent. Garlic has
attracted particular attention of modern medicine because
of its widespread health use around the world, and the
cherished belief that it helps in maintaining good health
warding off illnesses and providing more vigor. To date,
many favorable experimental and clinical effects of garlic
preparations, including garlic extract, have been reported.
These biological responses have been largely attributed to
i) reduction of risk factors for cardiovascular diseases and
cancer, ii) stimulation of immune function, iii) enhanced
detoxification of foreign compound, iv) hepatoprotec-
tion, v) antimicrobial effect and vi) antioxidant effect.
This review has been made indicating an overall view of
the efficacy of garlic in cardiovascular disease conditions
both in human and animals.
Historical perspective of garlic
It is fascinating to observe how cultures that never came
into contact with one another came to the same conclu-
sions about the role of garlic in health and disease. If folk
wisdom is not ignored, it may teach us valuable lessons.
Some of the earliest references to this medicinal and culi-
nary plant are found on Sumerian clay tablets dating from
2600–2100 BC. Garlic was an important medicine to the
ancient Egyptians listed in the medical text Codex Ebers
(ca. 1550 BC) specially for the working class involved in
heavy labor [1,2]. There is evidence that during the earliest
Olympics in Greece, garlic was fed to the athletes for in-
creasing stamina [1]. In ancient Chinese medicine, garlic
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was prescribed to aid respiration and digestion, most im-
portantly diarrhea and worm infestation [3]. Three an-
cient medical traditions in India i.e., Tibbi, Unani and
Auryveda, made extensive use of garlic as a central part of
the healing efficacy of plants [2]. The leading Indian an-
cient medical text, Charaka-Samhita  recommends garlic
for the treatment of heart disease and arthritis for over
many centuries. In another ancient Indian medical text-
book, Bower Manuscript (~300 AD), garlic was used for fa-
tigue, parasitic disease, digestive disorder and leprosy [4].
With the onset of Renaissance, increasing attention was
paid in Europe to the medical use of garlic. A leading phy-
sician of the 16th century, Pietro Mattiali of Siena, pre-
scribed garlic for digestive disorders, infestation with
worms and renal disorders, as well as to help mother dur-
ing difficult childbirth [2]. In England, garlic was used for
toothache, constipation, dropsy and plague [4]. In mod-
ern era scientists have been trying to validate many of
these properties of garlic, specially in terms of the identity
of the active components, their mechanisms of action and
exploring the potential benefits as food supplements.
Garlic preparations and their chemical com-
pounds
Raw garlic homogenate has been the major preparation of
garlic subjected to intensive scientific study, as because it
is the commonest way of garlic consumption. Raw garlic
homogenate is essentially same as aqueous extract of gar-
lic, which has been used in various scientific studies. Al-
licin (allyl 2-propenethiosulfinate or diallyl thiosulfinate)
is thought to be the principal bioactive compound present
in aqueous garlic extract or raw garlic homogenate. When
garlic is chopped or crushed, allinase enzyme, present in
garlic, is activated and acts on alliin (present in intact gar-
lic) to produce allicin. Other important sulfur containing
compounds presents in garlic homogenate are allyl me-
thyl thiosulfonate, 1-propenyl allyl thiosulfonate and γ-L-
glutamyl-S-alkyl-L-cysteine. The adenosine concentration
increases several-fold as the homogenate is incubated at
room temperature. The enzyme allinase responsible for
converting alliin (S-allyl cysteine sulphoxide) to allicin is
inactivated by heat. Thus the water extract of heat-treated
garlic contains mainly alliin. Since garlic powder is a sim-
ply dehydrated, pulverized garlic clove, the composition,
especially allinase activity of garlic powder is identical to
those of fresh garlic. However, dehydration temperature
should not exceed 60°C, above which allinase is inactivat-
ed [1].
Another widely studied garlic preparation is aged garlic
extract (AGE). Sliced raw garlic stored in 15–20% ethanol
for 20 months is refereed to as AGE. This whole process is
supposed to cause considerable loss of allicin and in-
creased activity of certain newer compounds, like S-allyl-
cysteine (SAC), S-allylmercaptocysteine, allixin and
selenium which are stable, highly bioavailable and signif-
icantly antioxidant [5]. Another recently identified anti-
oxidant compound of AGE is N-alpha-(1-deoxy-D-
fructos-1-yl)-L-arginine (Fru-Arg) which is not present in
raw or heat treated garlic [6].
Medicinally used garlic oil is mostly prepared by steam-
distillation process. Steam-distilled garlic oil consists of
the diallyl (57%), allyl methyl (37%) and dimethyl (6%)
mono to hexa sulfides. A typical commercial preparation
of garlic oil contains diallyl disulfide (DADS, 26%), dial-
lyl trisulfide (DATS, 19%), allyl methyl trisulfide (15%),
allyl methyl disulfide (13%), diallyl tetrasulfide (8%), al-
lyl methyl tetrasulfide (6%), dimethyl trisulfide (3%),
penta sulfide (4%) and hexa sulfide (1%). Oil-macerated
garlic oil contains the vinyl-dithiins and ajoenes. Ether ex-
tracted garlic oil (essential oil) contains nine times as
much of the vinyl-dithiins (5.7 mg/gm) and allyl sulfides
(1.4 mg/g) and four times as much of the ajoenes (0.4 mg/
g) [1].
Atherosclerosis and lipid metabolism
Atherosclerosis is a complex disease, characterized by an
excessive inflammatory, fibro-fatty, proliferative response
to damage of the artery wall involving several cell types,
particularly smooth muscle cells, monocyte-derived mac-
rophages, T-lymphocyte and platelets [7]. Hyperlipidemia
constitutes a major etiopathological factor for atheroscle-
rosis. The medicinal value of garlic is best known for its li-
pid lowering and antiatherogenic effects.
Animal studies
Several groups of investigators [8–14] studied the effects
of long term (2–9 months) feeding of garlic and garlic
preparations (2% garlic powder in diet) on experimental
atherosclerosis induced by a high-cholesterol diet in rab-
bits. Most of these studies reported a statistically signifi-
cant reduction in atheromatous lesions, particularly in the
aorta, that averaged about 50%.
The chronic effects of garlic on lipid metabolism in rats
were also encouraging. The duration of these studies was
at least 4 weeks. Garlic (1–4% in diet) and garlic protein
administration in hypercholesterolemic rats induced by a
high-cholesterol diet, significantly reduced serum choles-
terol, triglyceride and LDL cholesterol [11,15–20] but
there was no effect on serum HDL. Total lipid content and
cholesterol levels in liver were also decreased in rat after
chronic garlic consumption. Abramoviz et al. (1999) in-
vestigated the effect of allicin as an active component of
garlic on the formation of fatty streaks in aorta and lipid
profile in mice [21]. While no significant differences were
observed between blood lipid profiles, the microscopic
evaluation of formation of fatty streaks in the aortic sinusNutrition Journal 2002, 1 http://www.nutritionj.com/content/1/1/4
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showed that values for mice in the allicin treated groups
were significantly lower by nearly 50%.
Aged garlic extract 'Kyolic' also significantly inhibited the
development of thickened, lipid-filled lesions in the pre-
formed neointimas produced by balloon-catheter injury
of the right carotid artery in cholesterol-fed rabbits
[22,23].
Human studies
Since 1975 there have been more than 46 (from medline
search) human studies on lipid-lowering effects of garlic
and garlic preparations. These studies, were mostly rand-
omized, double blind, placebo-controlled using garlic
powder rather than raw garlic of 4–16 weeks, in hyperlip-
idemic patients. Most of these studies showed significant
decrease in serum cholesterol and serum triglyceride.
Only about one-third of these studies measured lipopro-
teins, where significant favorable changes in LDL-choles-
terol level (11–26% decrease) were consistently observed.
A few studies using garlic powder (having low allicin
yields) failed to show any lipid lowering effects [24,25].
During the last one decade (1993–2002), 18 clinical stud-
ies have been published regarding the hypolipedemic ef-
fect of garlic. Nine studies showed negative results and
garlic powder was used in seven of these studies (Table- 1)
[26–34]. The different composition and quantity of sulfur
components of different garlic preparations used in vari-
ous studies could account for the inconsistent findings. It
highlights the need for standardization of different garlic
preparations and to arrive at a valid conclusion. Other fac-
tors might include the subject recruitment, duration of
study, dietary control, lifestyle and methods of lipid anal-
yses [35,36].
Four meta-analysis of randomized, placebo-controlled
human studies on hypocholesterolemic effects of garlic
are available [35–38]. The analyses further detected that
the extent of cholesterol-lowering properties of garlic dif-
fered markedly from one study to another. Warshafsky
and his colleagues deduced from five randomized clinical
trials that hypercholesterolemic patients treated with gar-
lic had a mean plasma cholesterol concentration, that was
9% lower than that of patients treated with placebo [36].
Silagy and Neil (1994) analyzed sixteen trials, with data
from 952 subjects in the meta-analysis [35]. Garlic, in
powder and non-powder form, significantly lowered se-
rum lipid levels over a 1–3 month period. Serum choles-
terol fell by 8% with dried powder preparations and 15%
with non-powder preparations. Serum triglyceride level
also dropped significantly, while HDL-cholesterol was es-
sentially unchanged. Amongst the garlic powder prepara-
tions these effects appeared to be similar across the daily
dose range of 600–900 mg. Another meta-analysis [37] re-
vealed that there was no significant difference in the mean
concentrations of serum lipids, lipoproteins or apo A1 or
B amongst the groups receiving garlic (900 mg/day of
dried garlic powder standardized to 1.3% allicin) and pla-
cebo. In this meta-analysis, garlic was less effective in re-
ducing total cholesterol than suggested by previous meta-
analyses. However, in a more recent meta-analysis of thir-
teen trials [38], garlic reduced total cholesterol level from
baseline significantly more than placebo, while six diet-
controlled trials with the highest scores for methodologi-
cal quality revealed a nonsignificant difference between
garlic and placebo groups. The available data suggests that
garlic is superior to placebo in reducing total cholesterol
levels. However, the size of the effect is modest, and the
robustness of the effect is debatable. Therefore, the hypo-
cholesterolemic effect of garlic remains to be firmly estab-
lished.
Table 1: Studies showing no cholesterol lowering effect:
References Preparation Duration Dose
Ziaei et al., 2001 [26] Garlic powder (Garlet) 3 months 800 mg/day
Gardner et al., 2001 [27] Garlic powder 12 weeks 500, 1000 mg/day
Rahman et al., 2000 [28] Aged garlic extract 13 weeks 5 ml/day
Superko et al., 2000 [29] Garlic powder 3 months 900 mg/day
Byrne et al., 1999 [30] Garlic powder (Kwai) 6 months 900 mg/day
McCrindle et al., 1998 [31] Garlic powder (Kwai) 8 weeks 900 mg/kg
Berthold et al., 1998 [32] Steam-distilled garlic oil 12 weeks 10 mg/day
Isaacsohn et al., 1998 [33] Garlic powder (Kwai) 12 weeks 900 mg/day
Simons et al., 1995 [34] Garlic powder (Kwai) 12 weeks 900 mg/day
Luley et al., 1986 [25] Commercial dried garlic 6 weeks 600 mg/day
Lutomski, 1984 [24] Commercial garlic preparation 12 weeks –Nutrition Journal 2002, 1 http://www.nutritionj.com/content/1/1/4
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Possible mechanism/s
Protective effect of garlic on atherosclerosis has been at-
tributed to its capacity to reduce lipid content in arterial
wall. Garlic causes direct antiatherogenic (preventive) and
antiatherosclerotic (causing regression) effects at the level
of artery wall [39]. Garlic depressed the hepatic activities
of lipogenic and cholesterogenic enzymes such as malic
enzyme, fatty acid synthase, glucose-6 phosphate dehy-
drogenase and 3-hydroxy-3-methyl-glutaryl-CoA (HMG
CoA) reductase [40]. Garlic also increased the excretion of
cholesterol, as manifested by enhanced excretion of acidic
and neutral steroids after garlic feeding [20]. LDL isolated
from human subjects given AGE [41] and aqueous garlic
extract [42] was found to be significantly more resistant to
oxidation. These data indicate that suppressed LDL oxida-
tion may be one of the powerful mechanisms accounted
for the benefits of garlic in atherosclerosis [43]. Allicin was
identified initially as the active compound responsible for
antiatherosclerotic effect. However, recent in vitro studies
revealed that water-soluble organosulfur compounds, es-
pecially S-allyl cysteine (SAC), present in aged garlic ex-
tract and diallyl-di-sulfide (DADS), present in garlic oil
are also potent inhibitors of cholesterol synthesis [40,44].
Fibrinolytic activity
Inhibition of fibrinolytic activity (FA) or deficiency of the
factors involved might upset the hemostatic balance and
allow excessive fibrin deposition. In diabetes, hyperten-
sion, hypercholesterolemia etc, it is possible that distur-
bance in the coagulation-fibrinolytic system may be an
important factor leading to the development of thrombo-
sis and ischemia. Accordingly, the greater the FA, the more
favorable is the antithrombic effect. FA is generally deter-
mined by euglobulin lysis time. The patients who died
with acute or old myocardial infarction showed the high-
est values of plasma fibrinogen, euglobulin lysis time and
antiplasmin. This suggests that prognosis in myocardial
infarction is partly influenced by the degree to which plas-
ma fibrinolysis is impaired [45].
Animals studies
Marked rise in blood coagulability of rabbits that fol-
lowed 3 months of cholesterol feeding (0.2 g/kg/day) was
significantly reduced by the essential oils of garlic. Fibri-
nolytic activity was actually increased even above the nor-
mal control levels. The essential oils of garlic (equivalent
to 1 g/kg/day of raw bulbs) proved effective in mediating
fibrinolytic activity [10,46]. Experimental study also re-
vealed that garlic juice (raw garlic; 250 mg/day) had sig-
nificant effect in enhancing the fibrinolytic activity in
rabbit after receiving a cholesterol rich diet for 13 weeks
[47]. The plasma fibrinolytic activity in rabbit, which was
decreased on cholesterol feeding, was considerably in-
creased when this diet was supplemented with garlic [48].
Human studies
Almost all human studies on fibrinolytic activity of garlic
have been found to have positive effect (Table- 2). Acute
as well as chronic intake of garlic oil and raw garlic in-
creased fibrinolytic activity (FA). In 1975, Bordia first
demonstrated that garlic oil increased FA after 3 hours of
administration. Bordia also reported that chronic (3
weeks to 3 months) administration of garlic oil (dose:
equivalent to 1 gm/kg of fresh garlic) increased FA signif-
icantly ranging from 36% to 130% in healthy as well as
acute myocardial infarction patients [49–52]. Some other
investigators also found the same results [53–55]. Dried
garlic powder has been also tested for its fribinolytic activ-
ity. While two studies [24,25] showed no difference in FA,
one study [56] showed increased FA as well as tissue plas-
minogen activator activity after acute and chronic garlic
powder intake. Chutani and Bordia (1981) designed one
study to show that both raw and fried garlic significantly
enhance FA [53]. Frying removes the strong acrid smell of
garlic, but preserves it useful effects on FA. The rise in FA
has been observed within 6 hours of garlic administra-
tion, which showed that garlic has a rapid onset of action
and the effect is well maintained as long as garlic is being
taken. Recently Bordia (1998) found that intake (3
months) of ethyl acetate extract of crushed raw garlic also
increased FA [57].
Platelet aggregation
Platelet aggregation superimposed on an atherosclerosis
vessel is an antecedent event causing total blockage of
blood flow leading to myocardial infarction and throm-
boembolic diseases. Platelets adhere to the exposed colla-
gen, laminin and von Willebrand factor in the injured
vessel wall. This process is called platelet activation. Acti-
vation can also be produced by ADP and thrombin. The
activated platelets change shape, put out pseudopodia,
discharge their granules, and stick to other platelets, initi-
ating the process of platelet aggregation. Aggregation is
also fostered by platelet activating factor (PAF), a cytokine
secreted by neutrophil and monocytes as well as platelets
[59]. Studies have shown that garlic has great potential in
inhibiting platelet aggregation.
Animal studies
Pretreatment of rabbits with an aqueous extract of garlic
(500 mg/kg) significantly inhibited thromboxane-B2
(TXB2) synthesis (a potent platelet aggregator) and pro-
tected against thrombocytopenia induced by collagen or
arachidonate infusion. These observations indicate that
garlic may be beneficial in the prevention of thrombosis
[60]. Aqueous extract of garlic was found to inhibit plate-
let aggregation induced by ADP, epinephrine, collagen
and arachidonate in a dose-dependent manner in vitro
and inhibited biosynthesis of prostacyclin in rat aorta
[61]. A dose-dependent inhibition of cyclooxygenase ac-Nutrition Journal 2002, 1 http://www.nutritionj.com/content/1/1/4
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tivity and collagen-induced platelet aggregation was ob-
served in rabbit platelets treated with raw garlic in vitro.
The concentration required for 50% inhibition of the
platelet aggregation for garlic was calculated to be approx-
imately 6.6 mg/ml plasma. But boiled garlic was found to
be of little effect. This finding indicates that garlic may be
beneficial in the prevention of thrombosis if ingested raw
rather in a cooked form [62,63]. Garlic extract containing
diallyl disulfide and diallyl trisulfide, prevented acute
platelet thrombus formation in stenosed canine coronary
arteries [64]. Fresh garlic extract is effective in reducing
thromboxane formation by platelets both in vivo and in
vitro animal models of thrombosis. It was observed that
garlic inhibits thrombin-induced platelet synthesis of
TXB2 in a dose-and time-dependent manner in rabbits.
Maximum inhibition of TXB2 occurred between 0.5 h and
6 h at 25 and 100 mg/kg garlic. The rapid recovery of
platelet cyclooxygenase activity after infusion of a single
dose of garlic suggests that garlic should be taken more
frequently in order to achieve beneficial effects in the pre-
vention of thrombosis [65]. Garlic was also capable of de-
laying hyperthermia-induced platelet aggregation in
mouse pial arterioles, in vivo, which was comparable to
acetyl salicylic acid [66,67]. Ajoene, a constituent of essen-
tial oil of garlic, has been shown to inhibit in vitro platelet
aggregation in different species of animals i.e., cow, dog,
guinea-pig, horse, monkey, pig, rabbit and rat [68]. Under
in vivo flow conditions and in the presence of physiologi-
cal calcium levels, ajoene prevented thrombus formation
induced by severe vascular damage, mainly in arterial sites
with local low shear stress [69,70]. Makheja and Bailey
(1990) identified three main antiplatelet constituents,
namely adenosine, allicin and polysulfides in garlic [71].
Adenosine and allicin both inhibited platelet aggregation
without affecting cyclooxygenase and lipoxygenase me-
tabolites of arachidonic acid. The polysulfides inhibited
platelet aggregation as well as thromboxane synthesis. The
observed in vivo antiplatelet effects of ingesting garlic are
attributable more to adenosine than to allicin and
polysulfide constituents.
Human Study
In human studies a positive response to garlic has been
observed. Like enhancement of fibrinolysis, garlic also has
a beneficial effect on platelet adhesion or aggregation in
human (Table- 3). Bordia (1978) first showed the dose-
dependent inhibition of platelet aggregation by garlic
[72]. Raw garlic, garlic oil and other extract of garlic have
been shown to inhibit platelet aggregation in in vitro in-
duced by ADP, collagen, arachidonate, epinephrine and
calcium ionophore [57,61,73–75]. Chronic intake of gar-
lic powder and garlic oil also inhibits platelet aggregation
[28,50,55,76–79]. Single dose of garlic has also been
shown to inhibit platelet aggregation [54,56,80].
Possible mechanism/s
The antiplatelet mechanism of garlic is much more estab-
lished than its any other biological effects. Aqueous ex-
tract of garlic inhibited platelet aggregation induced by
ADP, collagen, arachidonate, epinephrine and calcium
ionophore A23187 in a dose-dependent manner [75]. It
was found that garlic reduced the formation of thrombox-
ane, inhibited the phospholipase activity and lipoxygen-
ase products formed in platelets. These effects may
explain, in part, inhibition of platelet aggregation. Fur-
ther, since garlic was also effective in inhibiting aggrega-
tion induced by calcium ionophore A23187 it may be
suggested that the antiaggregation effect may be related to
intraplatelet mobilization of calcium. Inhibition of epine-
phrine-induced aggregation by garlic extract may suggest
that it may be inhibiting uptake of calcium into platelets
thereby lowering cytosolic calcium concentrations [75].
Table 2: Fibrinolytic activity in human:
References Preparation Duration Effect
Bordia et al., 1975 [46] Essential garlic oil Acute effect Increased FA
Bordia et al., 1977 [10] Essential garlic oil 3 month Increased FA
Bordia et al., 1978 [50] Essential garlic oil 20 days Increased FA
Bordia et al., 1978 [58] Essential garlic oil 3 month Increased FA
Chutani and Bordia, 1981 [52] Fresh and fried garlic acute effect and 4 weeks Increased FA
Arora and Arora, 1981 [54] Essential garlic oil Acute effect Slightly increased FA
Arora et al., 1981 [55] Essential garlic oil 12 weeks Increased FA only after 4 weeks
Bordia et al., 1982 [51] Essential garlic oil 3 weeks Increased FA
Lutomski, 1984 [24] Dried garlic powder 12 weeks No increased in FA
Luley et al., 1986 [25] Dried garlic powder 6 weeks No increased in FA
Legnani et al., 1993 [56] Dried garlic powder Acute and 14 days Increased FA
Bordia et al., 1998 [57] Ethyl acetate extract of garlic 3 months Increased FANutrition Journal 2002, 1 http://www.nutritionj.com/content/1/1/4
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In regard to a specific mechanism of ajoene's antiplatelet
action, several suggestions have been made. Ajoene
strongly inhibits the metabolism of arachidonic acid by
both cyclooxygenase and lipoxygenase pathways [81,82],
thus inhibiting the synthesis of thromboxane A2 and 12-
HETE. Antiaggregatory effect of ajoene may also be caus-
ally related to its direct interaction with the putative fi-
brinogen receptor (GPIIb/IIa) [83]. The studies of
Jamaluddin et al (1988) demonstrated that ajoene inter-
acts with a purified hemoprotein implicated in platelet ac-
tivation [84]. Ajoene modifies the binding of the
hemoprotein with ligands deemed to be physiologically
relevant as effectors. Allicin inhibits human platelet aggre-
gation in vitro without affecting cyclooxygenase or throm-
boxane synthase activity or cyclic adenosine
monophosphate (AMP) levels. Allicin also inhibits plate-
let aggregation but does not alter the activity of vascular
prostacyclin synthase. However, it inhibits ionophore
A23187-stimulated human neutrophil lysosomal enzyme
release. Thus garlic appears to be in possession of compo-
nents which might exert their effects at various stages in-
volved in the process of platelet aggregation.
Blood pressure lowering effect
A general definition of hypertension is a systolic blood
pressure (SBP) of 140 mm Hg or higher or a diastolic
blood pressure (DBP) of 90 mm Hg or higher or both. Pre-
vention and proper management of hypertension decreas-
es the incidence of related morbidity and mortality. A
downward shift of 3 mm Hg in SBP decreases the mortal-
ity from stroke by 8% and from ischemic heart disease by
5% (Joint National Committee, 1993). Life style modifi-
cation are definitive therapy for some and adjunctive ther-
apy for all persons with hypertension (Joint National
Committee, 1997). Diets that are high in fruits, vegetables
and low-fat dairy products; have been shown to reduce
hypertension. Increased consumption of garlic is associat-
ed with lower incidence of hypertension in population.
Based on current information, garlic powder preparations
are considered for recommendation as adjuncts in the
treatment of hypertensive patients [90].
Animal Studies
In experimental animals, intravenous injection of garlic
extracts produced slight reductions in both systolic and di-
astolic pressures [91,92]. Oral administration of garlic re-
duced experimentally induced hypertension, bringing
blood pressure back to the normal range. For example 2.5
to 25 mg per kg of alcoholic garlic extract reduced blood
pressure by 10 to 50 mm Hg [93]. Blood pressure in dogs
has been significantly reduced for several hours following
intragastric administration of a small dose of garlic pow-
Table 3: Inhibition of Platelet aggregation (PA) in human:
References Preparations Duration Effect
Bordia, 1978 [72] Garlic In-vitro Dose-dependent Platelet aggrega-
tion
Vanderhock et al., 1980 [73] Garlic oil In vitro Inhibit PA
Boullin, 1981 [80] Fresh garlic Single Dose Inhibit PA
Ariga et al., 1981 [85] Methyl allyl trisulfide In vitro Inhibit PA
Arora and Arora, 1981 [54] Ether extract of garlic Single Dose Increased coagulation time
Bordia et al., 1982 [51] Ether extract of garlic 3 weeks Inhibit PA
Samson, 1982 [76] Essential garlic oil 10 days No PA activity
Apitz-Castro et al., 1983 [74] Garlic extract and 3 pure compo-
nent
In vitro Inhibit PA
Block et al., 1984 [86] Ajoene In vitro Inhibit PA
Srivastava, 1984 [61] Aqueous extract of garlic In vitro Inhibit PA
Srivastava, 1986 [75] Aqueous extract of garlic In vitro Inhibit PA
Harenberg et al., 1988 [77] Dried garlic powder 4 weeks No PA activity
Kiesewetter et al., 1991 [78] Garlic powder 4 weeks Inhibit PA
Kiesewetter et al., 1993 [87] Garlic powder 4 weeks Inhibit PA
Legnani et al., 1993 [56] Garlic powder Single Dose and 14 days Inhibit PA
Morris et al., 1995 [88] Oil extract (equivalent to 15 gm of 
raw garlic)
In-vitro and in-vivo (5 days) Inhibit PA in in-vitro No in-vivo PA 
activity
Bordia et al., 1998 [57] Ethyl acetate extract of garlic In-vitro study Inhibit PA
Sreiner and Lin, 1998 [79] Aged garlic extract 10 months Inhibit PA
Rahman and Billington, 2000 [28] Aged garlic extract 13 weeks Inhibit PA
Steiner and Li, 2001 [89] Aged garlic extract 6 weeks Dose dependent inhibition of PANutrition Journal 2002, 1 http://www.nutritionj.com/content/1/1/4
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der (as low as 2.5 mg/kg b.wt) [94]. Other animal experi-
ments on rats and dogs also indicate a 'normalizing' effect
of garlic on elevated blood pressure [93,95–98]. The anti-
hypertensive effect of garlic in these studies has been re-
peatedly confirmed.
Allicin, a major constituent of garlic, was also evaluated
for its antihypertensive effects. Chronic oral administra-
tion of allicin lowered blood pressure in hypertensive rats
[99,100]. Allicin also caused pulmonary vasodilatation in
isolated lung of rat [101]. Single as well as multiple doses
of aqueous garlic extract reduced thromboxane B2 and
prostaglandin E2 level and thereby reduced hypertension
in '2 kidney 1-clip' model of hypertension in rat [102].
Garlic also inhibited endothelin-1 induced contraction in
a dose-dependent manner in isolated rat pulmonary arter-
ies [103].
Garlic (100 mg/kg) administration for 5 days resulted in a
complete inhibition of acute hypoxic pulmonary vaso-
constriction in rat [104]. There was a marked decrease in
systolic blood pressure in spontaneously hypertensive rats
after oral administration of single dose of garlic [97]. Pro-
longation of life span was also found in hypertensive rats
by dietary supplementation with garlic [105].
Human study
Blood pressure lowering effect of garlic on human is given
in Table- 4. Leoper and DeBray recognized the hypoten-
sive effect of garlic in 1921 [106]. Damrau (1941) has re-
viewed the earlier literature, including his own
investigations on 26 patients [107]. Blood pressure reduc-
tion was observed in 85% of the patients, the average de-
cline being 12.3 mm Hg systolic (SBP) and 6.5 mm Hg
diastolic (DBP) blood pressure, over one-quarter of the
subjects experienced a decline in SBP of 20 mm Hg or
more.
Piotrowski (1948) has reviewed some of the early clinical
studies in which garlic was administered under controlled
conditions to hypertensive patients [108]. Two-fifths of
100 patients exhibited a 20 mm Hg or greater decline in
SBP generally within 1 week after initiation of treatment
with 0.6 to 1.2 g daily of a dialyzed, alcoholic garlic ex-
tract.
Studies with a dried garlic powder (Kwai tablets) showed
an average decrease in blood pressure of about 9% with
0.6 g garlic powder per day [77,109] and in a randomized
double blind trial, a beneficial effect of garlic on blood
pressure and blood lipids in mildly hypertensive subjects
was demonstrated [110]. Those reports point in the same
direction, that garlic can be useful in the control of mild
hypertension in many if not all cases.
Pektov (1979) has also cited several studies, mostly from
the Soviet Union and Bulgaria, which indicate that garlic
and its extracts exhibit antihypertensive activity [111]. Be-
sides subjective improvement, the results of these studies
indicated a moderate hypotensive effect involving a drop
in SBP of 20–30 mm Hg and in DBP of 10–20 mm Hg.
Another study in China (1986) on 70 hypertensive pa-
tients who were given garlic oil equivalent to 50 gm of raw
garlic/day, 47 patients showed moderate to marked reduc-
tion in blood pressure [112].
There is only one meta-analysis done by Silagy and Neil
(1994) [113]. Eight trials were identified all using the
same dried garlic powder preparation (Kwai). Data from
415 subjects were included in the analysis. Only three tri-
als were specifically conducted in hypertensive subjects.
Table 4: Blood pressure lowering effect in Human
References Preparation Duration Dose Effect
Ziaei et al., 2001 [26] Garlic tablet (Garlet) 3 months 800 mg/day ↓ hypertension
Qidwai, 2000 [115] Garlic in diet Chronic intake 134 gm/month ↓ SBP
McCrindle et al., 1998 [31] Kwai 8 weeks 900 mg/day No changes
Steiner et al., 1996 [116] Aged garlic extract 6 months 7.2 gm/day ↓ SBP & DBP
Simons et al., 1995 [34] Kwai 12 weeks 900 mg/day No changes
Jain et al., 1993 [117] Kwai 12 weeks 900 mg/day No changes
Mcmahan & Vargas, 1993 [118] Garlic powder Acute 2400 mg ↓ BP
Kiesewetter et al., 1991 [78] Garlic powder 4 weeks 800 mg/day ↓ DBP
Auer et al., 1990 [119] Kwai 12 weeks 600 mg/day ↓ SBP & DBP
Zimmerman et al., 1990 [120] Kwai 3 weeks 900 mg/day No changes
Vorberg et al., 1990 [121] Kwai 16 weeks 900 mg/kg ↓ SBP & DBP
Piotrowski, 1948 [108] Alcoholic extract of garlic 1 week 0.6–1.2 gm/day ↓ SBPNutrition Journal 2002, 1 http://www.nutritionj.com/content/1/1/4
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Of the seven trials that compared the effect of garlic with
that of placebo, three showed a significant reduction in
systolic blood pressure (SBP) and four in diastolic blood
pressure (DBP). The overall pooled mean difference in the
absolute change (from baseline to final measurement) of
SBP was greater in the subjects who were treated with gar-
lic than in those treated with placebo. For DBP the corre-
sponding reduction in the garlic-treated subjects was
slightly smaller. This meta-analysis suggest that this "gar-
lic powder preparation may be of some clinical use in sub-
jects with mild hypertension". However, there is still
insufficient evidence to recommend it as a routine clinical
therapy for the treatment of hypertensive subjects. More
rigorously designed and analyzed trials are needed for
firm conclusion.
Possible mechanism/s
Rashid and Khan (1985) have postulated that mechanism
of antihypertensive action of garlic is due to its prostaglan-
din like effects, which decreases peripheral vascular resist-
ance [92]. The gamma-glutamylcysteines are the
compounds in garlic that may lower blood pressure, as in-
dicated by their ability to inhibit angiotensin-converting
enzyme in in vitro [114]. Garlic modulates the production
and function of both endothelium derived relaxing and
constricting factors and this may contribute to its protec-
tive effect against hypoxic pulmonary vasoconstriction
[103]. Garlic elicits nitric-oxide-dependent relaxation in
pulmonary arteries. This hypothesis was explained by the
fact that NG-nitro-L-arginine methyl ester (L-NAME, a
NOS inhibitor) abolished the vasodilatory effect of garlic
[103,104]. But another study reported that pulmonary va-
sodilatory effect of allicin are independent of the synthesis
of NO, ATP-sensitive (K+) channel, activation of cycloox-
ygenase enzyme [101].
Diabetes mellitus
Diabetes mellitus is a group of diseases characterized by
high blood glucose levels resulting from defects in insulin
secretion, insulin action, or both. Abnormalities in the
metabolism of carbohydrate, protein, and fat are also
present [122]. Nutrition plays a primary role to control
blood glucose level and further complication.
Animal studies
Garlic was effective in reducing blood glucose in strepto-
zotocin-induced [123–126] as well as alloxan-induced
[127–132] diabetes mellitus in rats and mice. Most of the
studies showed that garlic can reduce blood glucose level
in diabetic mice [127,133], rats [124,129,130], and rabbit
[131,132]. Augusti & Sheela consistently showed that S-
allyl cysteine sulfoxide (alliin), a sulfur containing amino
acid in garlic (200 mg/kg b.wt.) has a potential to reduce
diabetic condition in rat almost to the same extent as did
glibenclamide and insulin [128–130]. Treatment of dia-
betic rats with garlic oil decreased serum acid and alkaline
phosphatase, serum alanine and asparate transferases, as
well as serum amylase in diabetic rats [123]. Aged garlic
extract is also effective to prevent adrenal hypertrophy, hy-
perglycemia and elevation of corticosterone in hyperglyc-
emic mice induced by immobilization stress [133]. Garlic
intake (6.25% by weight in diet) for 12 days reduced hy-
perphagia and polydipsia but did not alter hyperglycemia
and hypoinsulinaemia in streptozotocin-induced diabetic
mice [125]. Ingestion of garlic juice resulted in better uti-
lization of glucose in glucose tolerance test performed in
rabbits [132,134]. The ethyl alcohol, petroleum ether and
ethyl ether extracts of garlic produced a significant fall in
blood sugar levels in rabbits [131]. Allicin at a dose of 250
mg/kg is 60% as effective as tolbutamide in alloxan-in-
duced diabetic rabbit [132].
Human study
Hypoglycemic effect of garlic in human is not well stud-
ied. Chronic feeding of garlic oil and garlic powder
[78,135] showed significant decrease in blood glucose
level whereas some other studies [57,117,136] showed no
change of blood glucose level. All human studies (Table-
5), except one or two, showing effect of garlic on blood
glucose level on normal healthy individuals but not in di-
abetic patients. Thus the role of garlic in diabetic condi-
tion is yet to be confirmed.
Table 5: Hypoglycemic effect of garlic in Human
References Preparation Duration Dose Effect
Zhang et al., 2001 [135] Garlic oil & Allicin 11 weeks 8.2 mg/day 7.8 mg/day ↓ blood glucose
Li et al., 2000 [137] Garlicin 10 days 64 mg/day i.v. drip ↓ blood glucose
Bordia et al., 1998 [57] Ethyl acetate extract 3 months Eq to 1 gm raw garlic/day No change
Ali & Thomson, 1995 [136] Fresh garlic 16 weeks 3 gm/day No change
Jain et al., 1993 [117] Garlic powder 12 weeks 900 mg/day No change
Kiesewetter et al., 1991 [78] Garlic powder 4 weeks 800 mg/day ↓ blood glucoseNutrition Journal 2002, 1 http://www.nutritionj.com/content/1/1/4
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Possible Mechanism
Though the exact mechanism/s of garlic as antidiabetic
agent is still not clear but in-vivo [124,132] as well as in-
vitro [128] studies showed that garlic acts as an insulin
secretagogue in diabetic rats. Augusti & Sheela also pro-
posed that antioxidant effect of S-allyl cysteine sulfoxide
(isolated product from garlic) may also contribute for its
beneficial effect in diabetes [128]. Another proposed
mechanism is due to spare insulin from sulphydryl group.
Inactivation of insulin by sulphydryl group is a common
phenomenon. Garlic (allicin) can effectively combine
with compounds like cysteine and enhance serum insulin
[132]. Jain & Vyas proposed that garlic can act as an anti-
diabetic agent by increasing either the pancreatic secretion
of insulin from the beta cells or its release from bound in-
sulin [131].
Other cardioprotective properties of garlic
Animal study
Garlic has a significant antiarrhythmic effect in both ven-
tricular and supraventricular arrhythmias. Garlic powder
(1% added to a standard chow for an 8 week period) sig-
nificantly reduced ischemia reperfusion-induced ventricu-
lar fibrillation (VF) in isolated perfused rat heart [138].
Garlic dialysate suppressed premature ventricular contrac-
tions and ventricular tachycardia in ouabain-intoxicated
dogs as well as ectopic rhythms induced by isoprenaline
and aconitine on electrically driven left rat atria [139].
Garlic dialysate decreased the positive inotropic and
chronotropic effects of isoproterenol in a concentration
dependent manner. β-receptor blocking action of garlic
was also suggested by Martin et al [140]. The positive in-
otropism and chronotorpism induced by isoproterenol
were partially antagonized by preincubation of the rat
atria with the garlic dialysate. The ECG showed a regular
sinus bradycardic rhythm in garlic dialysate fed anaesthe-
tized rat [140]. Direct relaxant effect of cardiac muscles
was reported by Aqel et al [141]. Garlic juice inhibited
norepinephrine-induced contractions of rabbit and guin-
ea pig aortic rings. It also inhibited the force of contrac-
tion of isolated rabbit heart in a concentration-dependent
manner [141]. Only one study showed that aqueous garlic
extract increased the amplitudes of atrial complex 'p' wave
and the ventricular complex 'QRS' of the rat ECG. This is
suggestive of increase in voltage output of the atria and
ventricles probably in accordance with positive inotro-
pism [142].
Raw garlic homogenate augmented endogenous antioxi-
dants along with reduction of basal lipid peroxidation in
rat heart, liver and kidney in a dose dependent manner
[143,144]. Aged garlic extract (AGE) also exerted its anti-
oxidant action by scavenging reactive oxygen species
[145] and enhancing the cellular antioxidants, like re-
duced glutathione superoxide dismutase, catalase and
glutathione peroxidase of vascular endothelial cells
[146,147]. Augmented endogenous antioxidants on heart
and endothelial cells have important direct cytoprotective
effects, especially in the event of oxidant stress induced in-
jury. Recently, in our laboratory, we found that chronic
oral administration of garlic homogenate protected the rat
heart from in vitro ischemic reperfusion injury [148] and
oxidative stress induced by single dose of adriamycin
[149]. AGE has been shown to offer protection against the
cardiotoxic effects of doxorubicin, an antineoplastic agent
used in cancer therapy [150]. Feeding of garlic powder in
rats for 11 days had a protective effect on isoproterenol-in-
duced myocardial damage [151]. In another study, the
size of the ischemic zone was significantly reduced and
the onset of arrhythmia after occlusion of the descending
branch of the left coronary artery was significantly pro-
longed in rats fed with a standard chow enriched with 1%
garlic powder for 10 weeks [152]. Aqueous garlic extract
was also found to be effective in reducing Cu (+)-initiated
oxidation of low density lipoprotein (LDL) as measured
by photochemiluminescence method [42]. AGE also pro-
tected vascular endothelial cells from H2O2-induced oxi-
dant injury [153].
Human Study
Aortic stiffening is as much an important risk factor in car-
diovascular morbidity and mortality, as it serves as relia-
ble surrogate marker for clinical endpoints like
myocardial and cerebrovascular incidents. Elevated aortic
stiffness induces high systolic blood pressure, augmented
pulse pressure with increased ventricular afterload, re-
duced subendocardial blood flow and augmented pulsa-
tile stress in the peripheral arteries [154]. In population,
consuming garlic for long period, attenuation of age-relat-
ed increase in aortic stiffness has been observed. This sug-
gests a protective effect on the elastic properties of the
aorta related to aging in human [155]. This study also
showed that regular long term garlic powder intake pro-
tected endothelial cell from oxidative injury [155]. Twelve
week therapy with garlic powder (800 mg/day) was effec-
tive in patients with peripheral arterial occlusive disease
Stage II. There was a significant decrease of plasma viscos-
ity. It is also quite interesting that the garlic-specific in-
crease in walking distance did not appear to occur until
the 5th week of treatment [87]. Microcirculation of skin
increased by 48% after administration of 800 mg/day gar-
lic powder over a period of four weeks. Plasma viscosity
was decreased by 3.2% [78]. Kiesewetter also reported that
garlic improved blood fluidity and increased capillary per-
fusion [156]. Decreased plasma viscosity and increased
(55%) capillary skin perfusion were observed even after 5
hours of garlic powder administration [157]. All these
studies are summarised in Table- 6.Nutrition Journal 2002, 1 http://www.nutritionj.com/content/1/1/4
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Adverse effects
Considering the fact that garlic has been an integral part
of our diet for centuries, it is taken for granted that garlic
is safe in a wide range of doses. But a few isolated reports
highlight some of the adverse and toxic effects of garlic.
Animal study
Higher concentrations of garlic extract have been shown
to be clastogenic [158] in mice, which was appreciably re-
duced at lower concentrations. Prolong feeding of high
levels of raw garlic in rats has resulted in anemia, weight
loss and failure to grow due to lysis of red blood cells
[159]. Raw garlic juice at a dose of 5 ml/kg has resulted in
death of rats due to stomach injury [160]. Surviving rats
exhibited swelling of the liver, hypertrophy of the spleen
and adrenal glands, and the decrease of erythrocyte count
with various morphological changes after 3 and 8 days.
Aqueous garlic extract (200 gm/l drinking water) for 10
days exhibited significantly higher levels of aspartate ami-
notransferase (AST) due to liver injury. Histopathological
examination of liver showed focal nonspecific injury with
inflammatory cell infiltration in hepatocytes [161]. Chen
et al., (1999) have reported that treatment of rats with
fresh garlic homogenate for 7 days caused a significant de-
crease in liver catalase activity in doses of 2 and 4 gm/kg
[162]. The ultrastructural study carried out in our labora-
tory revealed significant loss of normal cellular architec-
ture of heart, liver and kidneys after 30 days feeding of raw
garlic homogenate at 1000 mg/kg/day dose [143,144].
Feeding of allicin (100 mg/kg/day) for 15 days in rats in-
creased the activity of liver lipase and alpha glucal phos-
phorylase and decreased glucose-6-phosphatase activity
[163]. The exact mechanism of such garlic induced altera-
tion in cell structure and function is not clear.
There is also some reported toxicity with garlic powder.
Chronic administration of garlic powder (50 mg/day) re-
sulted in inhibition of spermatogenesis in rats. Reduced
concentration of sialic acid in the testes, epididymis and
seminal vesicles together with decreased leydig cell func-
tion reflects antiandrogenic effect of garlic [164]. Higher
concentration of garlic powder (200 mg/ml) or allicin iso-
lated from garlic caused considerable cell injuries in the
porta hepatis zone in isolated perfused rat liver [165],
which was not observed at a lower concentration. Another
in vitro study showed that diallyl sulfide (oxidized product
of allicin) at 5 mM significantly decreased cell viability in
liver [166].
Garlic oil fed at a dose of 100 mg/kg after 24 hour fasting
has also been found to be lethal. The cause of death ap-
pears to be acute pulmonary edema with severe conges-
tion [161]. Garlic oil and Diallyl-disulfide (200 mg/kg
b.w.) significantly reduced body weight gain of rats [167].
Ajoene, a garlic derived natural compound, present in
other types of garlic oil, is an inhibitor as well as a sub-
strate of human glutathione reductase and expected to in-
crease the oxidative stress of the respective cell [168].
All the above mentioned toxicity reports can not be ex-
plained to its fullest extent but the sulphoxides present in
the garlic extract can undergo exchange reaction with the
tritable SH-groups of enzymes and other proteins in the
body spontaneously at physiological pH and temperature,
inhibiting their activity. Garlic has been demonstrated to
inhibit the alkaline phosphatase [161], papain, and alco-
hol dehydrogenase [169]. These enzyme interactions with
garlic components may be a reason for its toxicity.
Human study
Relatively few side effects were reported in clinical studies
using garlic and its preparations. Most of the reported side
effects were non-specific. Gastrointestinal discomfort and
nausea were the most frequent complaint [170]. A survey
by Koch (1995) showed that allergic reactions to garlic
were reported in a total of 39 publications between 1938
and 1994 [171]. Most of these cases involved an allergic
contact dermatitis, sometimes severe [172], which has
Table 6: Direct cardioprotective effect of garlic in Human
References Preparation Duration Dose Effect
Li et al., 2000 [137] Garlicin 10 days 64 mg/day i.v. drip ↓ Unstable angina
Breithaupt-Grogler et al., 1997 [155] Garlic powder 7 years 300 mg/day ↑ elastic property of 
blood vessels
Kiesewetter et al; 1993 [87] Garlic powder 12 weeks 800 mg/day ↓ peripheral arterial 
occlusive disease
Kiesewetter et al., 1991 [78] Garlic powder 4 weeks 800 mg/day ↓ plasma viscosity
Jung et al., 1991 [157] Garlic powder Single dose 900 mg/day ↓ plasma viscosity & ↑ 
skin perfusion
Kiesewetter et al; 1990 [156] Garlic powder Acute – ↑ capillary perfusionNutrition Journal 2002, 1 http://www.nutritionj.com/content/1/1/4
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been reported in people with occupational exposure to
garlic. There have also been sporadic reports of allergic
conjunctivitis, rhinitis, or bronchospasms occurring in re-
sponse to garlic inhalation or ingestion [173,174]. Other
reported side effects included bloating, headache, dizzi-
ness, and profuse sweating [170]. Ingestion of fresh garlic
and garlic powder may have additive effects with antico-
agulants or platelet aggregation inhibitors, leading in one
case to a life-threatening hemorrhage [175–179].
Conclusions
Epidemiological study shows an inverse correlation be-
tween garlic consumption and reduced risk of cardiovas-
cular disease progression [180–182]. The wealth of
scientific literature supports the proposal that garlic con-
sumption have significant cardioprotective effect, which
include both animal and human studies. But certain is-
sues regarding the proper use of garlic, i.e use of different
preparations available, dose, duration and interaction
with generic drugs should be optimized. Further research
should also be carried out to identify specific compounds
from garlic or garlic products that are responsible for most
of its biological effects.
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